Sato Yosuke, Shimizu Katsuyoshi, Iizuka Kazuki, Irie Ryo, Matsumoto Masaki, Mizutani Tohru
Department of Neurosurgery, Showa University School of Medicine, Tokyo, Japan.
J Neurol Surg B Skull Base. 2021 Dec 29;83(5):548-553. doi: 10.1055/s-0041-1740970. eCollection 2022 Oct.
Detailed studies assessing the factors related to delayed cure of hemifacial spasm (HFS) after microvascular decompression (MVD) are sparse. We aimed to evaluate the effect of 11 clinical factors on the time until the patient became spasm free after MVD. We enrolled 175 consecutive patients with HFS who underwent MVD between 2012 and 2018. The end point was defined as the time point at which the patient became spasm free based on the outpatient interview. Patients were divided into six groups depending on when they became spasm free after the operation, as follows: <7 days ( = 62), 7 days to 1 month ( = 28), 1 to 3 months ( = 38), 3 to 6 months ( = 25), 6 to 12 months ( = 17), and >12 months ( = 5). The median time to become spasm free after MVD was 30.0 days. Association of 11 factors (age, sex, laterality, number of offending arteries, vertebral artery compression, number of compression sites, compression at root detachment zone, preoperative Botox treatment, indentation of the brain stem on preoperative magnetic resonance image, transposition, and interposition) with spasm-free rate was assessed using the Cox's proportional hazards model. Spasm-free rate curve after MVD for the significant factor was obtained using the Kaplan-Meier method. In univariate and multivariate analyses, nontransposition was significantly related to delayed HFS cure after MVD (hazard ratio [HR], 0.60; 95% confidence interval [CI], 0.42, 0.87; = 0.0068 and HR, 0.60; CI, 0.43, 0.85; = 0.042, respectively). The spasm-free rate was higher in the transposition than in the nontransposition group ( = 0.0013). As shortening the time until spasm free after MVD improves patients' quality of life, transposition should be recommended. Prediction of spasm-free time could relieve the anxiety of postoperative patients.
评估微血管减压术(MVD)后半面肌痉挛(HFS)延迟治愈相关因素的详细研究较少。我们旨在评估11个临床因素对MVD后患者痉挛消失时间的影响。我们纳入了2012年至2018年间连续接受MVD的175例HFS患者。终点定义为根据门诊访谈患者痉挛消失的时间点。根据术后痉挛消失的时间,将患者分为六组,如下:<7天(n = 62),7天至1个月(n = 28),1至3个月(n = 38),3至6个月(n = 25),6至12个月(n = 17),以及>12个月(n = 5)。MVD后痉挛消失的中位时间为30.0天。使用Cox比例风险模型评估11个因素(年龄、性别、侧别、责任动脉数量、椎动脉压迫、压迫部位数量、神经根离断区压迫、术前肉毒杆菌毒素治疗、术前磁共振成像上脑干受压情况、转位和置入)与痉挛消失率的相关性。使用Kaplan-Meier方法获得显著因素的MVD后痉挛消失率曲线。在单因素和多因素分析中,未进行转位与MVD后HFS延迟治愈显著相关(风险比[HR],0.60;95%置信区间[CI],0.42,0.87;P = 0.0068和HR,0.60;CI,0.43,0.85;P = 0.042,分别)。转位组的痉挛消失率高于未转位组(P = 0.0013)。由于缩短MVD后痉挛消失的时间可改善患者的生活质量,因此应推荐转位。预测痉挛消失时间可缓解术后患者的焦虑情绪。